Echter Fortschritt in der Intensivmedizin muss auch in Zukunft noch finanzierbar sein - Plädoyer für einen öffentlichen Diskurs

Literatur

• 1 Boldt J. Können wir uns Fortschritte in der Intensivmedizin noch leisten?.  Dtsch Med Wochenschr. 2004;  129 (1 - 2) 36-40
• 2 The Acute Respiratory Distress Syndrome Network . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.  N Engl J Med. 2000;  342 (18) 1301-1308
• 3 Brook A D, Ahrens T S. et al . Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation.  Crit Care Med. 1999;  27 (12) 2609-2615
• 4 Kress J P, Pohlman A S. et al . Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.  N Engl J Med. 2000;  342 (20) 1471-1477
• 5 Rivers E, Nguyen B. et al . Early goal-directed therapy in the treatment of severe sepsis and septic shock.  N Engl J Med. 2001;  345 (19) 1368-1377
• 6 Annane D, Sebille V. et al . Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.  JAMA. 2002;  288 (7) 862-871
• 7 van den Berghe G, Wouters P. et al . Intensive insulin therapy in the critically ill patients.  N Engl J Med. 2001;  345 (19) 1359-1367
• 8 Society of Critical Care Medicine . Healthcare Resource Utilization Opinion Poll Questions and Answers.  Critical Connections. 2003;  Vol. 1 Number 3
• 9 Bernard G R, Vincent J L. et al . Efficacy and safety of recombinant human activated protein C for severe sepsis.  N Engl J Med. 2001;  344 (10) 699-709
• 10 Dellinger R P, Carlet J. et al . Surviving Sepsis Campaign for management of severe sepsis and septic shock.  Crit Care Med. 2004;  32 858-872
• 11 Schneider H. Gesundheitsökonomie in der Intensivmedizin.  Medizin im Dialog. 2002;  4 16-18